IL143632A0 - Pharmaceutical compositions containing lactobacillus - Google Patents
Pharmaceutical compositions containing lactobacillusInfo
- Publication number
- IL143632A0 IL143632A0 IL14363299A IL14363299A IL143632A0 IL 143632 A0 IL143632 A0 IL 143632A0 IL 14363299 A IL14363299 A IL 14363299A IL 14363299 A IL14363299 A IL 14363299A IL 143632 A0 IL143632 A0 IL 143632A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing lactobacillus
- compositions
- lactobacillus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11196598P | 1998-12-11 | 1998-12-11 | |
PCT/CA1999/001182 WO2000035465A2 (en) | 1998-12-11 | 1999-12-10 | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143632A0 true IL143632A0 (en) | 2002-04-21 |
Family
ID=22341404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14363299A IL143632A0 (en) | 1998-12-11 | 1999-12-10 | Pharmaceutical compositions containing lactobacillus |
Country Status (15)
Country | Link |
---|---|
US (1) | US6479051B1 (xx) |
EP (1) | EP1137423B1 (xx) |
JP (1) | JP2003522731A (xx) |
KR (1) | KR20010101171A (xx) |
AT (1) | ATE290391T1 (xx) |
AU (1) | AU1543400A (xx) |
BR (1) | BR9916062A (xx) |
CA (1) | CA2354054C (xx) |
DE (1) | DE69924141D1 (xx) |
ID (1) | ID30071A (xx) |
IL (1) | IL143632A0 (xx) |
NZ (1) | NZ512275A (xx) |
PL (1) | PL348973A1 (xx) |
TR (1) | TR200101699T2 (xx) |
WO (1) | WO2000035465A2 (xx) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2374937A1 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
US20020044926A1 (en) * | 1999-12-10 | 2002-04-18 | Gregor Reid | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
WO2002016554A1 (fr) * | 2000-08-25 | 2002-02-28 | Wakamoto Pharmaceutical Co.,Ltd. | Produits probiotiques contenant une bacterie de l'acide lactique |
SE521022C2 (sv) | 2001-09-20 | 2003-09-23 | Ellen Ab | Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa |
US7547527B2 (en) | 2000-10-06 | 2009-06-16 | Markus Baur | Use of probiotic lactic acid bacteria for balancing the skin's immune system |
JP5186077B2 (ja) * | 2000-12-18 | 2013-04-17 | プロバイオヘルス・エルエルシー | ラクトバシラス−カゼイke01株から得られたプロバイオティック化合物 |
BR0207019A (pt) * | 2001-02-06 | 2004-02-25 | Nestle Sa | Ligação de endotoxina através de bactérias de ácido láctico e bifidobactérias |
EE04580B1 (et) * | 2001-06-29 | 2006-02-15 | Tartu �likool | Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum |
BR0211384B1 (pt) * | 2001-07-23 | 2014-07-29 | Iams Company | Método e aparelho para produção de um produto alimentício para gatos e cães |
CN100478026C (zh) * | 2001-09-28 | 2009-04-15 | 纽特休迪克斯公司 | 用于生物学组分的传递系统 |
US20070098784A1 (en) | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
AU2003215472A1 (en) * | 2002-03-28 | 2003-10-13 | Jeremy Burton | Lactobacillus iners for the enhancement of urogenital health |
US20050100531A1 (en) * | 2002-06-13 | 2005-05-12 | John Bienenstock | Probiotic therapies |
EP1594560A4 (en) * | 2003-01-09 | 2007-06-06 | Univ Pennsylvania | COMPOSITIONS, METHODS AND KITS ENHANCING THE IMMUNOGENECITY OF A BACTERIAL VACCINE VECTOR |
US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
GB0410785D0 (en) * | 2004-05-14 | 2004-06-16 | Glycologic Ltd | Improved prebiotic |
US7955834B2 (en) * | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
US20060062774A1 (en) * | 2004-09-21 | 2006-03-23 | The Procter & Gamble Company | Compositions for maintaining and restoring normal urogenital flora |
US20060229244A1 (en) * | 2004-09-27 | 2006-10-12 | Robert Dorit | Engineered bacteriocins and bacteriocin combinations and methods for treating bacterial based infections |
JP2008517015A (ja) * | 2004-10-22 | 2008-05-22 | メディノバ アクチェンゲゼルシャフト | 胃腸病原菌に対して有用な乳酸菌、及び当該乳酸菌を含む組成物 |
WO2006045347A1 (en) * | 2004-10-22 | 2006-05-04 | Medinova Ag | Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens |
JP2008537885A (ja) * | 2005-04-15 | 2008-10-02 | ノース・キャロライナ・ステイト・ユニヴァーシティ | 細菌の付着およびストレス耐性を修飾する方法および組成物 |
US20070082035A1 (en) | 2005-10-06 | 2007-04-12 | New York Blood Center, Inc. | Anti-infective hygiene products based on cellulose acetate phthalate |
WO2008106372A1 (en) * | 2007-02-28 | 2008-09-04 | Mead Johnson Nutrition Company | Method for treating or preventing systemic inflammation |
PL210465B1 (pl) | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
US20110064706A1 (en) * | 2008-01-11 | 2011-03-17 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend |
US20090226548A1 (en) * | 2008-01-11 | 2009-09-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections using a synergistic cranberry derivative and d-mannose composition |
WO2010056198A1 (en) | 2008-11-17 | 2010-05-20 | Essum Ab | Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains |
EP2206506A1 (en) * | 2008-12-18 | 2010-07-14 | Bracco Imaging S.p.A | Probiotic formulations |
JP5645192B2 (ja) | 2009-07-16 | 2014-12-24 | 国立大学法人広島大学 | 口腔内疾患の予防、改善又は治療剤 |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
MX348611B (es) * | 2009-12-31 | 2017-06-21 | Milton Trachtman Ira | Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana. |
EP3311825A1 (en) | 2010-08-04 | 2018-04-25 | Thomas Julius Borody | Compositions for fecal floral transplantation and methods for making and using them |
EP2428214A1 (en) | 2010-09-14 | 2012-03-14 | HSO Health Care GmbH | Compositions for the vaginal and oral administration of lactobacillus and uses thereof |
EE05750B1 (et) * | 2011-02-25 | 2015-06-15 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine |
WO2012118535A1 (en) * | 2011-03-01 | 2012-09-07 | Quorum Innovations, Llc | Materials and methods for treating conditions associated with pathogenic biofilm |
ES2636439T3 (es) | 2011-03-09 | 2017-10-05 | Regents Of The University Of Minnesota | Composiciones y métodos para el trasplante de microbiota de colon |
WO2012122472A1 (en) * | 2011-03-09 | 2012-09-13 | Northwestern University | Compositions and methods for treatment of pain |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
KR101287126B1 (ko) * | 2011-10-28 | 2013-07-17 | 대상에프앤에프 주식회사 | 식물성유산균발효액을 함유하는 질염 및 요로감염 예방 및 치료용 약학 조성물 |
EP2836224A4 (en) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | COMPOSITIONS OF BIOZOOSE AND RELATED METHODS |
CN104302278B (zh) | 2012-03-29 | 2018-08-21 | 塞拉拜姆有限责任公司 | 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂 |
CN104755090B (zh) | 2012-04-05 | 2020-10-20 | 伦敦健康科学中心研究公司 | 用于除去有毒化合物的食品级细菌 |
FR2992973B1 (fr) | 2012-07-09 | 2015-12-18 | S P M D | Nouvelle souche de lactobacillus crispatus |
FR2992861B1 (fr) | 2012-07-09 | 2014-10-17 | Probionov | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
MX370537B (es) * | 2013-02-07 | 2019-12-17 | Novozymes As | Uso de leche descremada como portador de lactobacillus en la elaboración de una composición para la agregación de helycobacter pylori. |
WO2014152338A1 (en) | 2013-03-14 | 2014-09-25 | Kabadi Mohan | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
ITMI20130794A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche. |
ITMI20130793A1 (it) | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
CN108064132A (zh) | 2014-10-31 | 2018-05-22 | 霍勒拜欧姆公司 | 与病症的微生物治疗和诊断有关的方法和组合物 |
EP3064072A1 (en) | 2015-02-11 | 2016-09-07 | AB-Biotics S.A. | Probiotic lactobacillus strains for use in treating urinary tract infections |
EP3288394A4 (en) | 2015-04-28 | 2019-01-23 | Mars, Incorporated | PROCESS FOR THE PREPARATION OF A STERILIZED WASTE FOOD PRODUCT |
CN114990099A (zh) | 2015-05-11 | 2022-09-02 | 迈彼欧提克斯制药有限公司 | 用于使益生菌在使细菌于肠道中定植用途的固体颗粒上生长成益生菌生物膜的系统和方法 |
WO2016191356A1 (en) | 2015-05-22 | 2016-12-01 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10588926B2 (en) * | 2015-06-29 | 2020-03-17 | Ferring B.V. | Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis |
FR3048361B1 (fr) | 2016-03-01 | 2020-12-18 | Biose | Compositions pour le traitement des candidoses |
RU2022101485A (ru) | 2016-05-25 | 2022-04-27 | Майбиотикс Фарма Лтд. | Композиция и способы для микробиотной терапии |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
WO2018050650A1 (en) * | 2016-09-16 | 2018-03-22 | Dupont Nutrition Biosciences Aps | Bacteria |
WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
US11433102B2 (en) | 2017-04-05 | 2022-09-06 | Finch Therapeutics Holdings Llc | Compositions and methods for treating Parkinson's disease (PD) and related disorders |
US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
JP2020521760A (ja) | 2017-05-26 | 2020-07-27 | クレストヴォ・ホールディングス・エルエルシー | 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法 |
WO2019032573A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER |
JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス, インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
WO2020069280A1 (en) | 2018-09-27 | 2020-04-02 | Crestovo Holdings Llc | Compositions and methods for treating epilepsy and related disorders |
US20210268046A1 (en) * | 2020-02-18 | 2021-09-02 | HoneyHills TX, LLC | Cannabinoid & probiotic suppositories & methods of use |
US20230323332A1 (en) | 2020-08-28 | 2023-10-12 | Chr. Hansen A/S | Microencapsulation of microbial culture using octenyl succinic anhydride starch-chitosan complex coacervate |
CN112708583B (zh) * | 2021-01-29 | 2022-05-17 | 重庆第二师范学院 | 一种发酵乳杆菌lf-schy34及其应用 |
KR102337951B1 (ko) * | 2021-06-25 | 2021-12-13 | 주식회사 비피도 | 요로감염 개선, 예방 또는 치료를 위한 락토바실러스 헬베티쿠스 gut10 균주 및 이를 포함하는 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE469875C (sv) * | 1991-07-25 | 1997-02-05 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
US5733568A (en) * | 1993-12-03 | 1998-03-31 | Lafor Laboratories Limited | Micro-encapsulated lactobacilli for medical applications |
US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
CA2206674A1 (en) * | 1996-05-30 | 1997-11-30 | Gregor Reid | Lactobacillus therapies |
AU5113798A (en) * | 1996-11-29 | 1998-06-22 | Bio K & International Inc. | Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof |
-
1999
- 1999-12-10 NZ NZ512275A patent/NZ512275A/en not_active IP Right Cessation
- 1999-12-10 US US09/459,292 patent/US6479051B1/en not_active Expired - Lifetime
- 1999-12-10 ID IDW00200101506A patent/ID30071A/id unknown
- 1999-12-10 PL PL99348973A patent/PL348973A1/xx unknown
- 1999-12-10 JP JP2000587784A patent/JP2003522731A/ja active Pending
- 1999-12-10 CA CA2354054A patent/CA2354054C/en not_active Expired - Lifetime
- 1999-12-10 TR TR2001/01699T patent/TR200101699T2/xx unknown
- 1999-12-10 IL IL14363299A patent/IL143632A0/xx unknown
- 1999-12-10 AU AU15434/00A patent/AU1543400A/en not_active Abandoned
- 1999-12-10 DE DE69924141T patent/DE69924141D1/de not_active Expired - Lifetime
- 1999-12-10 EP EP99957817A patent/EP1137423B1/en not_active Expired - Lifetime
- 1999-12-10 AT AT99957817T patent/ATE290391T1/de not_active IP Right Cessation
- 1999-12-10 KR KR1020017007267A patent/KR20010101171A/ko not_active Application Discontinuation
- 1999-12-10 WO PCT/CA1999/001182 patent/WO2000035465A2/en not_active Application Discontinuation
- 1999-12-10 BR BR9916062-5A patent/BR9916062A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR200101699T2 (tr) | 2002-06-21 |
WO2000035465A2 (en) | 2000-06-22 |
ID30071A (id) | 2001-11-01 |
CA2354054A1 (en) | 2000-06-22 |
JP2003522731A (ja) | 2003-07-29 |
PL348973A1 (en) | 2002-06-17 |
BR9916062A (pt) | 2002-09-24 |
ATE290391T1 (de) | 2005-03-15 |
DE69924141D1 (de) | 2005-04-14 |
AU1543400A (en) | 2000-07-03 |
US6479051B1 (en) | 2002-11-12 |
CA2354054C (en) | 2011-04-12 |
EP1137423B1 (en) | 2005-03-09 |
WO2000035465A3 (en) | 2000-12-28 |
EP1137423A2 (en) | 2001-10-04 |
KR20010101171A (ko) | 2001-11-14 |
NZ512275A (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143632A0 (en) | Pharmaceutical compositions containing lactobacillus | |
WO2000071138A3 (en) | Oral administration of lactobacillus for the maintenance of health in women | |
HU9603251D0 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
NZ516020A (en) | Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria | |
IL156490A0 (en) | Probiotic compounds derived from lactobacillus casei strain ke01 | |
BG105564A (en) | Galantamine-containing composition with controlled release | |
MY116272A (en) | Immunity enhancing lactic acid bacteria | |
TNSN99254A1 (fr) | Boissons contenant des bacteries lactiques vivantes | |
HUP0402460A2 (hu) | Új tejsavbaktérium törzs és azt tartalmazó ehető készítmények, gyógyszerek és állatgyógyászati termékek | |
HK1046929A1 (zh) | 預防病原性細菌引起的腹瀉的雙歧杆菌 | |
HUP0203029A3 (en) | Oral form of administration containing probiotic micro-organisms | |
MXPA04004252A (es) | Del genero bifidobacterium y alimentos fermentados que utilizan la misma. | |
AP1563A (en) | Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis. | |
PT1353681E (pt) | ''bifidobactérias capazes de evitar a diarreia'' | |
EE200300220A (et) | Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod | |
MD20010055A (ro) | Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale | |
UA30798A (uk) | Спосіб пролонгованої терапії онкологічних хворих | |
UA67173A (en) | "bolmol" probiotic preparation | |
MD2527C2 (ro) | Asociaţie de tulpini de bacterii Bifidobacterium longum var. animalis şi Lactobacillus acidophilus - producătoare de vitamine B1, B2 şi B3 |